Cleared Special

K172227 - Endoscopic Injection Needle (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K172227 · Carbon Medical Technologies, Inc. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2017
Decision
29d
Days
Class 2
Risk

K172227 is an FDA 510(k) clearance for the Endoscopic Injection Needle. Classified as Endoscopic Injection Needle, Gastroenterology-urology (product code FBK), Class II - Special Controls.

Submitted by Carbon Medical Technologies, Inc. (St. Paul, US). The FDA issued a Cleared decision on August 23, 2017 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1500 - the FDA gastroenterology and urology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Carbon Medical Technologies, Inc. devices

Submission Details

510(k) Number K172227 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2017
Decision Date August 23, 2017
Days to Decision 29 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
101d faster than avg
Panel avg: 130d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code FBK Endoscopic Injection Needle, Gastroenterology-urology
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Inserted Through Endoscope For Injection Of A Solution, Gas, Or Implantable Materials Into Gi Or Gu Tissue.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FBK Endoscopic Injection Needle, Gastroenterology-urology

All 86
Devices cleared under the same product code (FBK) and FDA review panel - the closest regulatory comparables to K172227.
Disposable Endoscopic Injection Needles
K252021 · Changzhou New Med Micro-Medtech Co., Ltd. · Dec 2025
Injector Force Max Single Use Injector (NM-400L)
K252247 · Olympus Medical Systems Corporation · Oct 2025
EzVu Visual Vasopressor injector (EV-19)
K241595 · Veol Medical Technologies Pvt , Ltd. · Feb 2025
Endoscopic Injection Needles
K240675 · Promisemed Hangzhou Meditech Co., Ltd. · Oct 2024
injeTAK Adjustable Tip Needle (DIS199
K241523 · Laborie Medical Technologies, Corp. · Aug 2024
Disposable Injection Needles
K232200 · Ningbo Xinwell Medical Technology Co., Ltd. · Apr 2024